"A phenothiazine antipsychotic with effects similar to chlorpromazine. [PubChem]"@en . . . "approved"@en . . "2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine"@en . "thioridazine-2-sulfoxide"@en . "Take with food to reduce irritation."@en . "Thioridazine Thiomethyl Sulfoxide"@en . . . " "@en . "24 to 48 hours"@en . . "\"DrugSyn.org\":http://www.drugsyn.org/Mesoridazine.htm"@en . . . "Based upon animal studies, mesoridazine, as with other phenothiazines, acts indirectly on reticular formation, whereby neuronal activity into reticular formation is reduced without affecting its intrinsic ability to activate the cerebral cortex. In addition, the phenothiazines exhibit at least part of their activities through depression of hypothalamic centers. Neurochemically, the phenothiazines are thought to exert their effects by a central adrenergic blocking action."@en . . . . . "TPS-23"@en . . "10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine"@en . "4%"@en . . . . . . "10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine"@en . "Well absorbed from the gastrointestinal tract."@en . "Mesoridazine"@en . . . . . "Mesoridazinum"@en . " "@en . "Used in the treatment of schizophrenia, organic brain disorders, alcoholism and psychoneuroses."@en . . "5588-33-0"@en . . . . . "Mesoridazine"@en . . . . "Mesoridazina"@en . . . . . . . . . . . . . . "Oral LD₅₀ is 560 ± 62.5 mg/kg and 644 ± 48 mg/kg in mouse and rat, respectively. Symptoms of overdose may include emesis, muscle tremors, decreased food intake and death associated with aspiration of oral-gastric contents into the respiratory system."@en . . . "Humans and other mammals"@en . . . .